BlueCrest Capital Management Ltd - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlueCrest Capital Management Ltd ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q2 2023$35,342
-12.6%
25,4260.0%0.00%0.0%
Q1 2023$40,427
-86.9%
25,426
+266.3%
0.00%
-87.5%
Q3 2018$308,000
+20.3%
6,942
+36.1%
0.01%
-20.0%
Q3 2017$256,0005,0990.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$99,609,00022.32%
Bellevue Group AG 5,465,715$203,160,0002.81%
Rhenman & Partners Asset Management AB 455,000$16,912,0001.50%
Endurant Capital Management LP 135,901$5,051,0001.49%
Boxer Capital, LLC 975,000$36,241,0001.25%
DCF Advisers, LLC 56,500$2,100,0001.07%
Pentwater Capital Management LP 2,169,022$80,623,0001.04%
Nicholas Investment Partners, LP 235,855$8,767,0000.95%
Amia Capital LLP 20,464$761,0000.88%
HAMILTON LANE ADVISORS LLC 46,181$1,717,0000.83%
View complete list of ESPERION THERAPEUTICS INC NE shareholders